{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:23:16Z","timestamp":1789010596993,"version":"build-2803163510"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1111\/bjd.14269","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T03:46:50Z","timestamp":1446522410000},"page":"916-918","source":"Crossref","is-referenced-by-count":31,"title":["Dissecting cellulitis of the scalp treated with tumour necrosis factor-\u03b1 inhibitors: experience with two agents"],"prefix":"10.1093","volume":"174","author":[{"given":"Y.","family":"Mansouri","sequence":"first","affiliation":[{"name":"Department of Dermatology; Heart of England NHS Foundation Trust; Solihull West Midlands U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Martin-Clavijo","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University Hospitals Birmingham NHS Foundation Trust; Birmingham West Midlands U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Newsome","sequence":"additional","affiliation":[{"name":"University of Birmingham; NIHR Liver BRU and Centre for Liver Research; Birmingham West Midlands U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Heart of England NHS Foundation Trust; Solihull West Midlands U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"10.1111\/bjd.14269-BIB0001|bjd14269-cit-0001","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2133.1996.tb07952.x","article-title":"Dissecting cellulitis of the scalp: response to isotretinoin","volume":"134","author":"Scerri","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14269-BIB0002|bjd14269-cit-0002","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2133.2005.06536.x","article-title":"Modern external beam radiation therapy for refractory dissecting cellulitis of the scalp","volume":"152","author":"Chinnaiyan","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14269-BIB0003|bjd14269-cit-0003","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/archderm.138.10.1291","article-title":"Use of an 800-nm pulsed-diode laser in the treatment of recalcitrant dissecting cellulitis of the scalp","volume":"138","author":"Boyd","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.14269-BIB0004|bjd14269-cit-0004","first-page":"36","article-title":"Dissecting cellulitis of the scalp responding to intravenous tumor necrosis factor-\u03b1 antagonist","volume":"5","author":"Wollina","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1111\/bjd.14269-BIB0005|bjd14269-cit-0005","first-page":"981","article-title":"Refractory dissecting cellulitis of the scalp treated with adalimumab","volume":"7","author":"Sukhatme","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.14269-BIB0006|bjd14269-cit-0006","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2133.2008.08674.x","article-title":"Perifolliculitis capitis abscedens et suffodiens successfully controlled with infliximab","volume":"159","author":"Brandt","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14269-BIB0007|bjd14269-cit-0007","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archdermatol.2010.16","article-title":"3 cases of dissecting cellulitis of the scalp treated with adalimumab: control of inflammation within residual structural disease","volume":"146","author":"Navarini","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.14269-BIB0008|bjd14269-cit-0008","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13999","article-title":"Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of litterature","author":"Badaoui","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14269-BIB0009|bjd14269-cit-0009","first-page":"102","article-title":"Refractory dissecting cellulitis of the scalp successfully controlled with adalimumab","volume":"34","author":"Martin-Garc\u00eda","year":"2015","journal-title":"P R Health Sci J"},{"key":"10.1111\/bjd.14269-BIB0010|bjd14269-cit-0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/dth.12222","article-title":"Off-label use of TNF-\u03b1 inhibitors in a dermatological university department: retrospective evaluation of 118 patients","volume":"28","author":"Sand","year":"2015","journal-title":"Dermatol Ther"},{"key":"10.1111\/bjd.14269-BIB0011|bjd14269-cit-0011","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1111\/bjd.14269-BIB0012|bjd14269-cit-0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.12104","article-title":"Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review","volume":"168","author":"Blok","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14269-BIB0013|bjd14269-cit-0013","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-\u03b1 in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-\u03b1 agents?","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.14269-BIB0014|bjd14269-cit-0014","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14269-BIB0015|bjd14269-cit-0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bjd.12105","article-title":"Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa","volume":"168","author":"Savva","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14269","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14269\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:18:05Z","timestamp":1676384285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/174\/4\/916\/6617912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14269","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,27]]}}}